Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?
Wang, Daniel Wei L. ; Ferraz, Octavio Luiz Motta
The Journal of law, medicine & ethics, 2012-06, Vol.40 (2), p.188-196 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing Ltd
Texto completo disponível